🇺🇸 FDA
Patent

US 6326009

Enhancement of the cellular immune response

expired A61KA61K39/001169A61K45/05

Quick answer

US patent 6326009 (Enhancement of the cellular immune response) held by Biomira, Inc. expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Biomira, Inc.
Grant date
Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61K, A61K39/001169, A61K45/05, A61K47/646